Leave Your Message
ADT1692-Varlilumab Biosimilar-Anti-CD27/TNFRSF7 mAb-Research Grade
Hot

ADT1692-Varlilumab Biosimilar-Anti-CD27/TNFRSF7 mAb-Research Grade

  • Catalog Number ADT1692
  • Host CHO Cells
  • Species Human
  • Target CD27/TNFRSF7
  • Application Elisa, WB

The protein encoded by CD27 (CD27 molecule) is a member of the TNF receptor superfamily. It binds to ligand CD70 and plays a key role in regulating B cell activation and immunoglobulin synthesis. This receptor transduces signals that activate NF kappaB and MAPK8/JNK, including Akt signaling and TNF superfamily human ligand-receptor interactions and their related functions. An important homolog of this gene is LTBR.

We test for a wide range of parameters, including potency, stability, and safety, so you can trust that our biosimilar antibodies will perform reliably in your research.

Products Categories
Featured Products
recommended service
quick links
Contact Us

Product Background

When CD27 binds to CD70, the signaling cascade leads to T cell differentiation and clonal expansion. This cascade can also improve the survival and memory of cytotoxic T cells, and increase the production of certain cytokines. This receptor transmits signals, leading to activation of NF - κ B and MAPK8/JNK.

Product Specification

Catalog Number

ADT1692

Product Name

ADT1692-Varlilumab Biosimilar-Anti-CD27/TNFRSF7 mAb-Research Grade

Alias

1F5, CDX-1127

Isotype

IgG1 Kappa

Clonity

Monoclonal

Alternate Names

CD27 antibody, anti CD27, anti-CD27 antibody, human CD27 antibody, recombinant CD27, CD27 recombinant antibody, CD27 blocking antibody, TNFRSF7 recombinant antibody, TNFRSF7 blocking antibody, anti-TNFRSF7antibody

Official Symbol

CD27/TNFRSF7

Species

Human

Expression Host

CHO Cells

Reactivity

Human

CAS Number

1393344-72-3

Product Description

Varlilumab (INN, development code CDX-1127) is a monoclonal antibody designed for immunotherapy for solid tumors and hematologic malignancies. It is an anti-CD27 antibody and helps activate T-cells.

Mechanism of Action

Varlilumab is a monoclonal antibody targeting 4-1BB (CD137), a costimulatory receptor on T-cells.

Metabolism

Varlilumab has a long half-life and is distributed throughout the bloodstream and tissues.

Gene ID

939

Size

100ug,1mg,5mg

Research Area

Cancer

Application

Elisa, WB

Purity

>95% as determined by SDS-PAGE

Concentration

Batch dependent

Buffer

Supplied in PBS, PH7.5

Storage

Store at -20 °C for 12 months. Store at -80 °C for long term storage.

Shipping Condition

Shipped on ice packs.

Note

This product is for research use only. 

Reference

1. Dong MP, et al. Am J Pathol, 2022 Oct. PMID 35963463
2. Kibler A, et al. Front Immunol, 2022. PMID 35154145,
3. Galliano I, et al. Ital J Dermatol Venerol, 2022 Jun. PMID 34282858

 

FAQ

Leave Your Message